| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Aligos Therapeutics, Inc. (ALGS) has 10 insiders with recent SEC Form 4 filings, including 6 buys and 0 sells. ALGS is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 105.8K | $659.4K | - | |
| Other | 37.5K | $233.5K | - | |
| Other | 23.3K | $145.2K | - | |
| Other | 9.4K | $58.9K | - | |
| Dir | 5.9K | $36.5K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 25, 2023 | Nuechterlein Carole | Director, 10% Owner | Buy | 7,933,601 | $0.76 | $6,004,149.24 | +256.6% | +10.8% | -41.2% | |
| Oct 20, 2020 | Novo Holdings A/s58 | 10% Owner | Buy | 200,000 | $15.00 | $3,000,000.00 | +8.3% | - | - | |
| Oct 20, 2020 | Versant Venture Capital Vi, L.P.64 | 10% Owner | Buy | 200,000 | $15.00 | $3,000,000.00 | +30.2% | - | - | |
| Oct 20, 2020 | Vivo Capital Viii, LLC57 | 10% Owner | Buy | 550,000 | $15.00 | $8,250,000.00 | +18.4% | - | - | |
| Oct 20, 2020 | Woiwode Thomas | Director | Buy | 200,000 | $15.00 | $3,000,000.00 | +30.2% | - | - |